Fresenius Medical Care AG FMS

About Fresenius Medical Care AG (FMS): stock profile, AI score and financials

Fresenius Medical Care AG (FMS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FMS at 60.0/100 on a composite quality score built from its SEC filings, placing it at rank #886 of 2,925 stocks — the top half of the AI-ranked universe. FMS scores in the top quartile across revenue scale (92.2), earnings quality (89.7). Areas of concern include institutional flow (21.7) and revenue growth (26.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2025), Fresenius Medical Care AG reports quarterly revenue of $5.1B, net income of $327.1M, an operating margin of 11.7%. Top institutional holders of FMS by reported 13-F value include PZENA INVESTMENT MANAGEMENT, MORGAN STANLEY, DODGE & COX, based on the most recent SEC filings. FMS trades on the NYSE exchange and files with the SEC under CIK 1333141. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Fresenius Medical Care AG directly from SEC EDGAR.

SEC EDGAR: CIK 1333141 →